Bank of America Merrill Lynch and Lazard have emerged with lead advisory roles on the largest takeover announced so far in 2017.

US healthcare group Johnson & Johnson has agreed a $30 billion acquisition of Actelion, a Swiss biotech business, according to a joint statement from the companies on January 26.